Annual risk of infection with Mycobacterium tuberculosis

European Respiratory Journal

Volumn 25, Issue 1, 2005, Pages 181-185

  Rieder, H ^a,b  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b Intl Union Against TB/Lung Disease ^*  (Switzerland)

Author keywords

Epidemiology; Tuberculosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; TUBERCULIN;

ANALYTIC METHOD; ARTICLE; CALCULATION; CHILDHOOD DISEASE; COMMUNITY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; HEALTH SURVEY; HUMAN; IMMUNOASSAY; INCIDENCE; INFECTION RISK; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLING; STATISTICAL ANALYSIS; TUBERCULIN TEST; TUBERCULOSIS; VEIN PUNCTURE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BCG VACCINE; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PROGRAM EVALUATION; RISK ASSESSMENT; SEX DISTRIBUTION; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; VACCINATION; WORLD HEALTH;

EID: 13444261361     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00103804     Document Type: Article

References (46)

1. Rieder HL. Opportunity for exposure and risk of infection: the fuel for the tuberculosis pandemic. Infection 1995; 23: 1-3.
2. Muench H. Derivation of rates from summation data by the catalytic curve. J Am Stat Assoc 1934; 29: 25-38.
3. Nyboe J. Interpretation of tuberculosis infection age curves. Bull World Health Organ 1957; 17: 319-339.
4. Cauthen GM, Pio A, ten Dam HG. Annual risk of tuberculous infection (WHO/TB/88.154). Geneva, World Health Organization, 1988.
5. Cauthen GM, Pio A, ten Dam HG. Annual risk of tuberculous infection. 1988. Bull World Health Organ 2002; 80: 503-511.
6. Stýblo K, Meijer J, Sutherland I. Tuberculosis Surveillance Research Unit Report No. 1: the transmission of tubercle bacilli; its trend in a human population. Bull Int Union Tuberc 1969; 42: 1-104.
7. Sutherland I, Fayers PM. The association of the risk of tuberculous infection with age. Bull Int Union Tuberc 1975; 50: 70-81.
8. Grzybowski S, Allen EA. The challenge of tuberculosis in decline. A study based on the epidemiology of tuberculosis in Ontario, Canada. Am Rev Respir Dis 1964; 90: 707-720.
9. Rouillon A. The International Tuberculosis Surveillance Research Unit (TSRU): the first 30 years. Int J Tuberc Lung Dis 1998; 2: 5-9.
10. Snider DE Jr, Cauthen GM. Tuberculin skin testing of hospital employees: infection, "boosting", and two-step testing. Am J Infect Control 1984; 12: 305-311.
11. Narain R, Nair SS, Chandrasekhar P, Rao GR. Problems connected with estimating the incidence of tuberculous infection. Bull World Health Organ 1966; 34: 605-622.
12. Bulla A. Worldwide review of officially reported tuberculosis morbidity and mortality (1967-1971-1977). Bull Int Union Tuberc Lung Dis 1981; 56: 111-117.
13. Roelsgaard E, Iversen E, Bløcher C. Tuberculosis in tropical Africa. An epidemiological study. Bull World Health Organ 1964; 30: 459-518.
14. National Tuberculosis Institute Bangalore. Tuberculosis in a rural population of South India: a five-year epidemiological study. Bull World Health Organ 1974; 51: 473-489.
15. Rouillon A. The mutual assistance programme of the IUATLD. Development, contribution and significance. Bull Int Union Tuberc Lung Dis 1991; 66: 159-172.
16. Enarson DA. Principles of IUATLD collaborative tuberculosis programmes. Bull Int Union Tuberc Lung Dis 1991; 66: 195-200.
17. Styblo K. The first round of the National Tuberculin Survey in Tanzania, 1983-1987. Tuberculosis Surveillance Research Unit of the IUATLD Progress Report 1989; 2: 101-116.
18. Styblo K, Muwinge H, Chum HJ, et al. The second round of the national tuberculin survey in Tanzania, 1988-1992. Tuberculosis Surveillance Research Unit Progress Report 1995; 1: 140-191.
19. Styblo K. Preliminary results of the third round of the national tuberculin survey in 19 regions: Tanzania 1993-1997. Tuberculosis Surveillance Research Unit Progress Report 1998; 2: 31-66.
20. Rieder HL. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tuber Lung Dis 1995; 76: 114-121.
21. Chum HJ, O'Brien RJ, Chonde TM, Graf P, Rieder HL. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993. AIDS 1996; 10: 299-309.
22. Rana FS, Hawken MP, Mwachari C, et al. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 2000; 24: 23-29.
23. Harries AD, Nyangulu DS, Kangombe C, et al. The scourge of HIV-related tuberculosis: a cohort study in a district general hospital in Malawi. Ann Trop Med Parasitol 1998; 91: 771-776.
24. Range N, Ipuge YA, O'Brien RJ, et al. Trend in HIV prevalence among tuberculosis patients in Tanzania, 1991-1998. Int J Tuberc Lung Dis 2001; 5: 405-412.
25. Mwaba P, Maboshe M, Chintu C, Squire B, Nyirenda S, Zumla A. The relentless spread of tuberculosis in Zambia: trends over the past 37 years (1964-2000). S Afr Med J 2003; 93: 149-152.
26. Odhiambo JA, Borgdorff MW, Kiambih FM, et al. Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996. Am J Public Health 1999; 89: 1078-1082.
27. Styblo K. The relationship between the risk of tuberculous infection and the risk of developing infectious tuberculosis. Bull Int Union Tuberc Lung Dis 1985; 60: 117-119.
28. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65: 2-20.
29. Rieder HL. Epidemiologic basis of tuberculosis control. Paris, International Union Against Tuberculosis and Lung Disease, 1999.
30. World Health Organization. Tuberculosis handbook (WHO/TB/98.253). Geneva, World Health Organization, 1998.
31. Koch R. Ueber bacteriologische Forschung [On bacteriological research]. Dtsch Med Wochenschr 1890; 16: 756-757.
32. Seibert FB. History of the development of purified protein derivative tuberculin. Am Rev Tuberc 1941; 44: 1-8.
33. World Health Organization. Comité d'Experts pour la Standardisation Biologique. Cinquième rapport. 7. Tuberculine [Expert Committee on Biological Standardization. Fifth report. 7. Tuberculin]. Tech Rep Ser 1952; 56: 6-7.
34. Landi S. Production and standardization of tuberculin. In Kubica GP, Wayne LG, eds. The mycobacteria. Vol. 1. New York, Marcel Dekker Inc., 1984; pp. 505-535.
35. Magnusson M, Bentzon MW. Preparation of purified tuberculin RT 23. Bull World Health Organ 1958; 19: 829-843.
36. Arnadottir T, Rieder HL, Trébucq A, Waaler HT. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuber Lung Dis 1996; 77: Suppl. 1, 1-19.
37. Chadha VK, Vaidyanathan PS, Jagannatha PS, Unnikrishnan KP, Mini PA. Annual risk of tuberculous infection in the northern zone of India. Bull World Health Organ 2003; 81: 573-580.
38. Filers PHC, Borgdorff MW. Modeling and correction of digit preference in tuberculin surveys. Int J Tuberc Lung Dis 2004; 8: 232-239.
39. Neuenschwander BE, Zwahlen M, Kim SJ, Engel RR, Rieder HL. Trends in the prevalence of infection with Mycobacterium tuberculosis in Korea from 1965 to 1995: an analysis of seven surveys by mixture models. Int J Tuberc Lung Dis 2000; 4: 719-729.
40. Neuenschwander BE, Zwahlen M, Kim SJ, Lee EG, Rieder HL. Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated with Bacillus Calmette-Guérin in South Korea. Am J Epidemiol 2002; 155: 654-663.
41. Neuenschwander BE. Bayesian mixture analysis for tuberculin induration data. International Union Against Tuberculosis and Lung Disease. www.tbrieder.org/research/start_research.htm. Date last updated: March 1 2004.
42. Narain R, Geser A, Jambunathan MV, Subramanian M. Some aspects of a tuberculosis prevalence survey in a South Indian district. Bull World Health Organ 1963; 29: 641-664.
43. Bellete B, Coberly J, Link Barnes G, et al. Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations. Clin Infect Dis 2002; 34: 1449-1456.
44. Mazurek GH, Villarino ME, Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON®-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR Recomm Rep 2003; 52: 15-18.
45. Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001; 163: 824-828.
46. Brouwer M. Skin test reactions in tuberculin surveys: preventive treatment with isoniazid or not? Thesis, Master in Community Medicine, University of Utrecht, 2001; pp. 1-28.